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Nephropathia epidemica (NE) caused by Puumala hantavirus (PUUV) is themost commonhemorrhagic feverwith renal syndrome
(HFRS) in Europe.The infection activates immunological mechanisms that contribute to the pathogenesis and characteristics of the
illness. In this study wemeasured cerebrospinal fluid (CSF) neopterin concentration from 23 acute-phase NE patients.We collected
data on kidney function, markers of tissue permeability, haemodynamic properties, blood cell count, length of hospitalisation,
inflammatory parameters, and ophthalmological properties. The neopterin levels were elevated (>5.8 nmol/L) in 22 (96%) NE-
patients (mean 45.8 nmol/L); these were especially high in patients with intrathecal PUUV-IgM production (mean 58.2 nmol/L,
𝑃 = 0.01) and those with elevated CSF protein concentrations (mean 63.6 nmol/L, 𝑃 < 0.05). We also observed a correlation
between the neopterin and high plasma creatinine value (𝑟 = 0.66, 𝑃 = 0.001), low blood thrombocyte count (𝑟 = −0.42, 𝑃 < 0.05),
andmarkedly disturbed refractory properties of an eye (𝑟 = 0.47, 𝑃 < 0.05). Length of hospitalisation correlated with the neopterin
(𝑟 = 0.42,𝑃 < 0.05; male patients 𝑟 = 0.69,𝑃 < 0.01). Patients with signs of tissue oedema and increased permeability also had high
neopterin concentrations. These results reinforce the view that PUUV-HFRS is a general infection that affects the central nervous
system and the blood-brain barrier.
1. Introduction
Nephropathia epidemica (NE) is an emerging infectious dis-
ease caused by Puumala hantavirus carried and spread by
bank voles (Myodes glareolus) (PUUV) [1]. This hemor-
rhagic fever with renal syndrome (HFRS) has an acute
onset of fever 2–5 weeks after the exposure. The typical
symptoms of the acute illness include impaired renal func-
tion, gastrointestinal symptoms, thrombocytopenia, blurred
vision, and occasionally hemorrhagic complications. Central
nervous system (CNS) symptoms are also common; many
patients experience headache, insomnia, vertigo, nausea,
nuchal rigidity, and confusion. Pituitary haemorrhage, gener-
alized seizures, meningoencephalitis, and acute disseminated
encephalomyelitis have been reported [1]. Despite these
potential complications, in general the course of the illness
is mild and most patients recover without suffering any long-
term complications.
Endothelial cells and monocytes are thought to be the
primary targets of hantaviruses. The infection may lead to
activation of monocyte/macrophage lineage and expression
of interleukin-6 (IL-6), interleukin-10 (IL-10), and tumour
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necrosis factor-alpha (TNF-𝛼) the serum levels of which have
been correlated with the severity of the infection [2–4].
It seems evident that immune-mediated mechanisms are
at least partly responsible for the symptoms of the illness;
activation of monocytes/macrophages followed by cytokine
production, complement activation, and a T-cell response
may contribute to the pathogenesis of HFRS [1]. Increased
vascular permeability and capillary leakage in acute NE
may be of immunological origin. In addition, there is a
genetic susceptibility to severe disease in individuals with
HLAB8DR3 haplotype [5].
In the present study, we investigated a marker of mono-
cyte/macrophage lineage activation in the CNS during acute
NE. We analyzed the concentrations of neopterin, a pro-
inflammatory factor produced mainly by macrophages, in
CSF samples of acute-phase NE patients and then searched
for associations between the CSF neopterin levels and other
clinical characteristics of the illness.
2. Materials and Methods
2.1. Patient Population. The patient population of this study
was described in detail elsewhere [6]. The CSF sample was
collected from 42 of the 58 patients. For this analysis, we
included 23 hospitalised NE patients from whom adequate
acute-phase CSF samples were available for the determi-
nation of neopterin concentration. The study protocol was
explained to each patient and they had the right to participate,
refuse, or withdraw from the study or any single examination
of the study according to the Helsinki Declaration. The
ethics Committee of the Oulu University Hospital approved
the study and all participants signed an informed consent
form.
2.2. Clinical Data. Patients were examined as previously
described [6]. The patients’ CNS symptoms were evaluated
and CSF samples were collected. Data of kidney function
(daily urine output and plasma creatinine), tissue perme-
ability and tissue oedema (serum/CSF albumin ratio, weight
change during hospitalisation), and haemodynamic parame-
ters (systolic blood pressure, heart rate) were collected. The
length of hospitalisation as a marker of disease severity was
recorded. In addition, blood haemoglobin (Hb) concentra-
tion, thrombocyte count, blood white cell count (BWC),
serum albumin concentration, plasma C-reactive protein
(CRP) concentration, CSF glucose, protein and albumin
concentrations, and CSF white cell count were determined.
The patients were also examined by an ophthalmologist as
described earlier [7]. In addition, the previously described
results of brain magnetic resonance imaging (MRI), elec-
troencephalography (EEG), and human leukocyte antigen
(HLA) haplotyping were considered [6].
2.3. Virological and Immunological Analysis. The labora-
tory diagnosis of NE was based on PUUV serology that
was initially analysed using a commercial enzyme-linked
immunosorbent assay of IgM antibodies (Reagena Puumala
IgM EIA Kit, Reagena, Toivala, Finland). In selected cases,
the samples were also analysed with an indirect immunoflu-
orescence test for PUUV-IgG which displayed a granular
staining pattern in cases of typical acute infection [8]. CSF
and serum PUUV IgM and IgG antibody levels were titrated
as described earlier [6].TheCSF neopterin concentrationwas
analysed using a commercial enzyme-linked immunosor-
bent assay (Neopterin ELISA, IBM International GMBH,
Hamburg, Germany). Neopterin concentrations were cal-
culated from optical density values of duplicate samples
using cubic spline interpolation with a not-a-knot condition
(http://www.akiti.ca/CubicSpline.html).
2.4. Statistical Methods and Data Analysis. Multivariate anal-
ysis of the results was not possible due to the low number
of patients. Instead, Pearson bivariate correlation test and
Mann-Whitney 𝑈 test were used to analyse the significance
of the findings. A 𝑃 value of <0.05 was considered signifi-
cant. In the case of ophthalmological parameters, the values
measured from the right eye of each patient were used.
PASW Statistics 18 (SPSS Inc., Chicago, IL, USA) was used
for statistical analysis.
3. Results
3.1. CSF Neopterin. CSF samples from 23 patients with acute
NEwere available for analysis of the neopterin concentration.
Most (𝑛 = 22, 96%) patients had an elevated CSF neop-
terin level compared to those seen in healthy individuals
(<5.8 nmol/L) [9, 10].TheCSF neopterinmean concentration
in male (𝑛 = 15) and female (𝑛 = 8) patients was 46.9 nmol/L
and 43.9 nmol/L, respectively. The neopterin concentration
was 63.6 nmol/L and 29.6 nmol in CSF in samples with
elevated (>500mg/L, 𝑛 = 11) or normal (150–500mg/L, 𝑛 =
12) protein level, respectively (𝑃 < 0.05, Mann-Whitney 𝑈
test) (Table 1). Patients with a positive CSF PUUV-IgM find-
ing (𝑛 = 14) had higher CSF neopterin level (58.2 nmol/L)
than those negative for CSF PUUV-IgM (26.5 nmol/L, 𝑛 = 9,
𝑃 = 0.01). The CSF white cell count did not show any asso-
ciation with the neopterin level and there was no difference
in the CSF neopterin levels of different age categories. CSF
neopterin level correlated with the length of hospitalisation
(𝑟 = 0.42, 𝑃 < 0.05) (Table 2); this finding was most evident
among the male patients (𝑟 = 0.69, 𝑃 < 0.01).
3.2. CSF Neopterin and Blood Cell Count. There was a
correlation between the blood thrombocyte levelmeasured in
the morning of the lumbar puncture and the CSF neopterin
concentration (𝑟 = −0.42, 𝑃 < 0.05) (Table 2). In addition,
the blood Hb concentration in the morning of the lumbar
puncture was lower in those patients with a high CSF
neopterin concentration (𝑟 = −0.44, 𝑃 < 0.05). There was no
association between the blood white cell count and the CSF
neopterin level.
3.3. Kidney Function, Tissue Oedema, and Permeability. The
highest plasma creatinine level (𝑃 < 0.01) and the plasma
creatinine concentration measured in the morning of the
lumbar puncture (𝑟 = 0.66, 𝑃 = 0.001) correlated with
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Table 1: Summary of statistical analysis of the CSF neopterin concentration and the CSF PUUV IgM, protein concentration, white cell count,
and CSF/serum albumin ratio.
PUUV IgM CSF protein (mg/L) CSF white cells (×10e6/L) CSF/serum albumin
− + 150–500 >500 0–3 >3 <0.1 ≥0.1
CSF neopterin (nmol/L) 26.5 58.2 29.6 63.6 42.8 50.5 32.2 68.6
Significance 𝑃 = 0.01 𝑃 < 0.05 ns 𝑃 = 0.01
Table 2: Summary of the statistical correlation between the CSF
neopterin concentration and plasma creatinine and blood thrombo-
cyte count measured in the morning of lumbar puncture, duration
of hospitalisation, weight change during the hospitalisation, and
change in the refractory properties of an eye between the acute-
phase and one month later.
CSF neopterin
Plasma creatinine 𝑟 = 0.66
𝑃 = 0.001
Blood thrombocytes 𝑟 = −0.42
𝑃 < 0.05
Length of hospitalization 𝑟 = 0.42
𝑃 < 0.05
Weight change 𝑟 = −0.53
𝑃 < 0.05
Change in refraction of eye 𝑟 = 0.47
𝑃 < 0.05
the CSF neopterin concentration (Table 2). Weight change
during the hospitalisation correlated with the CSF neopterin
concentration (𝑟 = −0.53, 𝑃 < 0.05) indicating that patients
with the most evident tissue oedema had the highest CSF
neopterin level. CSF/serum albumin ratio as a marker of
tissue permeability was also associated with CSF neopterin
concentration (𝑃 = 0.01).
3.4. Ophthalmological Findings and CSF Neopterin. An ele-
vated CSF neopterin concentration was associated with a
large difference in the refractory properties of the eye when
this was first measured during the acute phase and then
month after recovery (𝑟 = 0.47, 𝑃 < 0.05) (Table 2). None
of the other ophthalmological parameters were linked with
the CSF neopterin measurement.
3.5. Other Clinical Examinations. The patients were analyzed
for brain MRI, EEG, and HLA haplotype and the results are
described in detail in our previous paper [6]. The number of
patients or number of abnormal findings was too low to allow
statistical analysis.
4. Discussion
An elevated CSF protein concentration and a raised white
cell count are commonly seen in acute NE and many patients
display evidence of intrathecal antibody production against
PUUV [6, 11, 12]. In addition, PUUV RNA has been detected
in the pituitary gland and the CSF [13, 14]. A previous study
has also confirmed elevated levels of neopterin, IL-6, and
interferon-gamma in the CSF of acute NE patients [12]. Based
on these data, it seems evident that the CNS is affected in
acute NE. However, it remains partly unclear whether the
clinical symptoms and the laboratory findings originate from
the direct viral invasion of the brain or from increased tissue
permeability due to activation of the immune system.
Activation of monocyte/macrophage lineage and subse-
quent cytokine expression leading to T-lymphocyte stimu-
lation may contribute to the pathogenesis of acute NE [15].
The intensity of activation of these cells has been shown to
account for the course of the disease in individual patients
[2–4]. In our patient population, the CNS disease in acute
NE appeared to be dependent on these similar inflammatory
pathways. In addition, it can be concluded from our current
results that the activity of the same pathways may also play
a role in NE ocular involvement. The CSF neopterin level
was high in our patients with intrathecal PUUV antibody
production and those with high CSF protein concentration.
An analogous observation has been documented in the
occurrence of permanent neurological complications, and
even death, in human herpes virus (HSV) encephalitis [16].
In addition, elevated CSF neopterin concentrations have also
been detected in other CNSmanifestations of viral infections,
for example, acute human immunodeficiency virus (HIV)
infection and chronic HIV encephalopathy [10, 17].
Elevated neopterin levels have been detected in acute
dengue fever and high neopterin levels were found especially
in those dengue patients with increased tissue permeability
[18]. A similar observation has been made in HIV infection
in which a high neopterin concentration indicated increased
blood-brain barrier (BBB) permeability [19]. Neopterin has
also been shown to play a role in the increased permeability
of the BBB in patients with cerebral small vessel disease [20].
In our patient cohort, we detected an association between the
CSF neopterin concentration and the weight change during
the hospitalisation. We also observed a correlation between
the CSF neopterin and the CSF/serum albumin ratio. These
results indicate that the inflammatory process with activated
monocytes/macrophages may play a role in the increased
tissue permeability also in acute NE. Further conclusions
regarding the mechanism of increased tissue permeability
based on our results are not warranted; a major limitation
of our study is that we were not able to examine additional
inflammatory markers from both CSF and blood due to
low sample volumes. Future studies should be designed to
evaluate broad range of indicators of activated pathways from
multiple locations.
In our study, high neopterin levels correlated with mark-
ers of disease severity: high plasma creatinine concentrations
and low blood thrombocyte counts were encountered in
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patients with high neopterin values. Moreover, the elevated
CSF neopterin level correlated with the length of hospitalisa-
tion especially inmale patients. Interestingly, a previous study
has found a gender-dependent difference in the cytokine
responses to hantavirus infection [21]. It is also known that
the male gender is associated with a more severe clinical
course of NE and young male patients are at a special risk of
developing serious CNS complications during acute NE [22].
In summary, it seems possible that an inflammatory reac-
tion of the CNS in acute NE is at least partly influenced by the
monocyte/macrophage activity. Increased tissue permeability
due to inflammatory reaction is most likely essential, but it
is also possible that direct PUUV invasion of the CNS may
play a significant role. Investigation of mechanisms leading
to the injury of the blood-brain barrier and the increased
tissue permeability, however, may further explain the biology
of CNS disease in acute NE.
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